Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.

<h4>Background</h4>Rosacea is a chronic inflammatory skin disorder of uncertain etiology. Evidence suggests the underlying pathogenesis is modulated by abnormal inflammatory and vascular responses. Thalidomide is a synthetic derivative acid with anti-inflammatory and anti-angiogenic properties. Howe... View More